We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · May 11, 2022

Local Therapy Plus Systemic Therapy vs Local Therapy Alone for Stage I pT1aN0M0 HER2+ Breast Cancer

Cancer

 

Additional Info

Cancer
A comparison of local therapy alone with local plus systemic therapy for stage I pT1aN0M0 HER2+ breast cancer: A National Cancer Database analysis
Cancer 2022 Apr 01;[EPub Ahead of Print], L Cao, CW Towe, R Shenk, N Stabellini, AL Amin, AJ Montero

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading